Global Nanotechnology Enabled Coatings for Aircraft Market trends analysis report 2020 the future of the industries is predicted on the basis of the current scenario, income, and growth opportunities. Assortments of graphical introduction systems are utilized to show the realities. In the end, we examine some inside and outside variables that drive or breaking point the Nanotechnology Enabled Coatings for Aircraft Market.

(SPECIAL OFFER GET UPTO 15% DISCOUNT ON THIS REPORT)

Request for Sample at:

https://www.marketinsightsreports.com/reports/01031709966/global-nanotechnology-enabled-coatings-for-aircraft-market-research-report-2020/inquiry?mode=52

The global Nanotechnology Enabled Coatings for Aircraft market is valued at 30 million US$ in 2020 is expected to reach 58 million US$ by the end of 2026, growing at a CAGR of 9.7% during 2021-2026

Nanotechnology is the science of making or working with things that are so small that they can only be seen using a powerful microscope.The top three companies, PPG, MDS Coating Technologies and Powdermet, have 47% of the market share

The prominent players are

PPG, MDS Coating Technologies, Powdermet, ZKJN, FlightShield, Luna Innovtions, Kimetsan, Applied Thin Films, ToughGuard, EnvAerospace, Ceramic Pro

Nanotechnology Enabled Coatings for Aircraft Breakdown Data by ApplicationCommercial Aircraft

Military Aircraft

Nanotechnology Enabled Coatings for Aircraft Breakdown Data by TypeAnti-corrosion & Abrasion Nano Coatings

Anti-icing Nano Coatings

Nano Thermal Coatings

The segment of nano thermal coatings holds a comparatively larger share in global market, which accounts for about 63%. The military aircraft holds an important share in terms of applications, and accounts for 68% of the market share.

This report provides insights on the following pointers:

Browse this Report:

https://www.marketinsightsreports.com/reports/01031709966/global-nanotechnology-enabled-coatings-for-aircraft-market-research-report-2020?mode=52

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

[emailprotected]

[emailprotected]

All the reports that we list have been tracking the impact of COVID-19 the market. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team

Go here to see the original:
Nanotechnology Enabled Coatings for Aircraft Market Insights, Top Manufacturers and Industry Outlook 2020 to 2026 - Latest Herald

10x Technology 3M 3rd Millennium 3rdTech Bayer Material Science and Cortex

Nanotechnology Market: Competitive Landscape

The last chapter of the Nanotechnology market research report focuses exclusively on the competitive landscape. It examines the main market players. In addition to a brief overview of the business, analysts provide information on their assessment and development. The list of important products in preparation is also mentioned. The competitive landscape is analyzed by understanding the companies strategies and the initiatives they have taken in recent years to overcome intense competition.

Nanotechnology Market: Drivers and Restraints

The report explains the drivers of the future of the Nanotechnology market. It assesses the different forces which should have a positive impact on the whole market. Analysts have looked at investments in research and development for products and technologies, which should give players a significant boost. In addition, the researchers undertook an analysis of the evolution of consumer behavior which should have an impact on the cycles of supply and demand in the Nanotechnology market. In this research report, changes in per capita income, improvement in the economic situation and emerging trends were examined.

The research report also explains the potential restrictions on the Nanotechnology market. The aspects assessed are likely to hamper market growth in the near future. In addition to this assessment, it offers a list of opportunities that could prove lucrative for the entire market. Analysts offer solutions to turn threats and restrictions into successful opportunities in the years to come.

Nanotechnology Market: Regional Segmentation

In the following chapters, analysts have examined the regional segments of the Nanotechnology market. This gives readers a deeper insight into the global market and allows for a closer look at the elements that could determine its evolution. Countless regional aspects, such as the effects of culture, environment and government policies, which affect regional markets are highlighted.

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=15416&utm_source=COD&utm_medium=007

What will the report contain?

Market Dynamics: The report contains important information on influencing factors, market drivers, challenges, opportunities and market trends as part of the market dynamics.

Global Market Forecast: Readers receive production and sales forecasts for the Nanotechnology market, production and consumption forecasts for regional markets, production, sales and price forecasts for the Nanotechnology market by type and consumption forecasts for the Nanotechnology market per application.

Regional Market Analysis: It can be divided into two different sections: one for the analysis of regional production and one for the analysis of regional consumption. Here, analysts share gross margin, prices, sales, production, CAGR, and other factors that indicate the growth of all regional markets examined in the report.

Market Competition: In this section, the report provides information on the situation and trends of competition, including mergers and acquisitions and expansion, the market shares of the three or five main players and the concentration of the market. Readers could also get the production, revenue, and average price shares of manufacturers.

Key Players: The report provides company profiles for a decent number of leading players in the Nanotechnology market. It shows your current and future market growth taking into account price, gross margin, income, production, service areas, production locations and other factors.

Complete Report is Available @ https://www.verifiedmarketresearch.com/product/nanotechnology-market/?utm_source=COD&utm_medium=007

We also offer customization on reports based on specific client requirement:

1- Free country level analysis for any 5 countries of your choice.

2- Free Competitive analysis of any market players.

3- Free 40 analyst hours to cover any other data points

About us:

Verified market research partners with the customer and offer an insight into strategic and growth analyzes, Data necessary to achieve corporate goals and objectives. Our core values are trust, integrity and authenticity for our customers.

Analysts with a high level of expertise in data collection and governance use industrial techniques to collect and analyze data in all phases. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research reports.

Contact us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

Get Our Trending Report

https://www.marketresearchblogs.com/injection-molding-machine-market-size-growth-analysis-opportunities-business-outlook-and-forecast-to-2026/

Tags: Nanotechnology Market Size, Nanotechnology Market Trends, Nanotechnology Market Forecast, Nanotechnology Market Growth, Nanotechnology Market Analysis

Read more from the original source:
Nanotechnology Market 2020 Break Down by Top Companies, Applications, Challenges, Opportunities and Forecast 2026 Cole Reports - Cole of Duty

VALENCIA, Spain, April 17, 2020 /PRNewswire/ -- Sesderma, a company specialized in Nanotechnology, has managed to encapsulate Lactoferrin (LF) and vitamin C in a lipid bubble or nanoliposome made of phosphatidyl choline, to boost the immunity of the body. The company has named this combination as Lactyferrin. The size of this liposome is 100 nm. The nano-liposome protects LF from its destruction by digestive juices and the intact protein passes through the duodenum and passes into the general circulation, where its bioavailability is very high. (Ishikado et al, 2005, Serrano et al).

LF plays an important role in immune regulation and defense mechanisms against bacteria, fungi and viruses. Antibacterial activity is related to the deprivation of the iron environment which is essential for bacterial growth. Antiviral activity is associated with the effect of acting as a competitor of cell membrane receptors commonly used by viruses to enter cells. Specifically, lactoferrin prevents the binding of virus to the host cell.

Lactyferrin can also suppress replication of the virus after the virus enters the cell as in the case of AIDS (Puddu et al, 1998).

Since liposome is made of soy lecithin (phosphatidyl choline), LF is biodegradable and biocompatible, which means it is very safe.

In a statement, Dr Gabriel Serrano founder of Sesderma and a dermatologist with more than 40 years of experiencehas said that in Valencia Spain, he personally has treated 75 COVID-19 patients with moderate to severe clinical features (4 of them intubated) and has administered Lactyferrin solution to all of them. The outcome is very satisfying and based on this outcome, a clinical trial on larger base of 300 patients has started in National hospitals Hospital Ifema (Madrid), Hospital La Paz (Madrid) and Hospital de Manises (Valencia)

Further, he said,"Many patients admitted to our local hospitals are patients over the age of 70 who have very low zinc levels, and this can contribute to the severity of the infection. Zinc supplements have been proposed in COVID-19 infections (Zhang & Liu, 2020). Interestingly, the combined administration of nano encapsulated LF and Zinc may exert a more potent antiviral effect."

For more information about Sesderma and Lactyferrin, visit https://www.sesderma.com/es_es/home

Photo: https://mma.prnewswire.com/media/1156675/Dr_Serrano_Founder_of_Sesderma.jpg Logo: https://mma.prnewswire.com/media/1156685/Sesderma_Logo.jpg

Continued here:
Sesderma Laboratories Communicates the Effectiveness of Lactyferrin Forte Solution in Boosting Immunity - P&T Community

Results showed a greater than 100-fold increase in uptake of Cardiols nanoparticles in heart failure hearts compared with control hearts

Cardiol Therapeutics Inc. (TSX:CRDL) (OTCQX:CRTPF) (Cardiol or the Company), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, is pleased to announce that data describing Cardiols nanotechnology approach to drug delivery were submitted by the Companys international research collaborators and accepted for presentation at the American College of Cardiologys (ACC) 69th Annual Scientific Session & Expo together with the World Congress of Cardiology, held virtually from March 28-30.

Results from this study, conducted at the Houston Methodist DeBakey Heart & Vascular Center, showed that there was a greater than 100-fold increase in uptake of Cardiols nanoparticles in heart failure hearts compared with control hearts in a pre-clinical model of non-ischemic heart failure. The nanoparticles localized within the diseased hearts, predominantly in areas of fibrosis. Fibrosis is an important component of the pathology of heart failure and is primarily responsible for the stiffening and reduced function of the heart muscle. Moreover, the nanoparticles accumulated within the cytoplasm of the cultured fibroblasts. This evidence of Cardiols nanoparticles preferentially accumulating intracellularly in fibroblasts shows potential for the successful delivery of anti-fibrotic drugs, such as cannabidiol, to the diseased region of the heart.

These results are exciting and provide new insights into how nanotherapeutics may be utilized to target the anti-fibrotic properties of cannabidiol to fibrous tissue in the failing heart, said Dr. Arvind Bhimaraj, MD, MPH, Interim Division Chief of the Division of Heart Failure and Co-director of the Heart Failure Translational Research Laboratory at Houston Methodist DeBakey Heart & Vascular Center and a member of the Clinical Steering Committee for Cardiols planned international clinical trial in acute myocarditis. The specific targeting of the fibrotic tissue in the heart offers the potential to utilize drugs more effectively to prevent the progression of heart failure.

Cardiols proprietary nanotechnology is designed to enable the distribution of water insoluble drugs within the blood (aqueous) circulation, improve pharmacokinetics, and facilitate drug accumulation in the failing heart. Cardiols nanoparticles are based on a patented family of biocompatible and biodegradable amphiphilic block co-polymers made from polyethylene glycol (PEG) and polycaprolactone (PCL). Both PEG and PCL have a long history of safe use in humans.

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) is focused on producing pharmaceutical cannabidiol (CBD) products and developing innovative therapies for heart diseases, including acute myocarditis and other causes of heart failure. The Companys lead product, CardiolRx, is formulated to be the most consistent cannabidiol formulation on the market. CardiolRx is pharmaceutically produced, manufactured under cGMP, and is THC free (<5 ppm). The Company also plans to commercialize CardiolRx in the billion-dollar market for medicinal cannabinoids in Canada and is pursuing distribution opportunities in Europe and Latin America.

In heart failure, Cardiol is planning an international clinical study of CardiolRx in acute myocarditis, a condition caused by inflammation in heart tissue, which remains the most common cause of sudden cardiac death in people less than 35 years of age. The Company is also developing proprietary nanotechnology to uniquely deliver pharmaceutical cannabidiol and other anti-inflammatory drugs directly to sites of inflammation in the heart associated with heart failure. Heart failure is the leading cause of death and hospitalization in North America with associated annual healthcare costs in the U.S. alone exceeding $30 billion. For further information about Cardiol Therapeutics, please visitcardiolrx.com.

For further information, please contact:

David Elsley, President & CEO +1-289-910-0850david.elsley@cardiolrx.com

Trevor Burns, Investor Relations +1-289-910-0855trevor.burns@cardiolrx.com

Cautionary statement regarding forward-looking information:

This news release contains forward-looking information within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, that address activities, events or developments that Cardiol Therapeutics Inc. (Cardiol) believes, expects or anticipates will, may, could or might occur in the future are forward- looking information. Forward-looking information is frequently identified by the use of words such as plans, expects, projects, intends, believes, anticipates, forecasts, and other similar words and phrases, including variations (and negative variations) of such words and phrases, or may be identified by statements to the effect that certain actions, events or conditions may, could, should, would, or will be taken, occur or be achieved. Forward-looking information contained herein may include, but is not limited to, statements with respect to: future events; the future performance or the intended business strategy of Cardiol, including, but not limited to, the plan to commercialize CardiolRx and the planning of an international clinical study of CardiolRx in acute myocarditis; the potential for Cardiols licensed drug encapsulation and delivery technologies to enhance the bioavailability of pharmaceuticals; managements expectations regarding estimated future pharmaceutical research and development opportunities, collaborations and prospects; the success and proposed timing of Cardiols product development activities; the ability of Cardiol to develop its product candidates; Cardiols plans to research, discover, evaluate and develop additional products; Cardiols proposed future collaborations to advance Cardiols lead nanoformulations into clinical development; and the potential for Cardiols cannabinoid-based products to provide sources of future revenue. Forward-looking information contained herein reflects the current expectations or beliefs of Cardiol based on information currently available to it and is subject to a variety of known and unknown risks and uncertainties and other factors that could cause the actual events or results to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information. These risks and uncertainties and other factors include that the success of Cardiols product candidates will require significant capital resources and years of clinical development efforts; the results of clinical testing and trial activities of Cardiols products; Cardiols ability to obtain regulatory approval and market acceptance of its products; Cardiols ability to raise capital and the availability of future financing; Cardiols lack of operating history; unforeseeable deficiencies in the development of Cardiols product candidates; uncertainties relating to the availability and costs of financing needed in the future for Cardiols research and development initiatives; Cardiols ability to manage its research, development, growth and operating expenses; the potential failure of clinical trials to demonstrate acceptable levels of safety and efficacy of Cardiols product candidates; Cardiols ability to retain key management and other personnel; risks related to fluctuations in medicinal cannabinoid markets in Canada and worldwide; uncertainties regarding Cardiols ongoing collaborative and manufacturing partnerships; uncertainties regarding results of researching and developing products for human use; Cardiol competes in a highly competitive and evolving industry; Cardiols ability to obtain and maintain current and future intellectual property protection; and other risks and uncertainties and factors. These risks, uncertainties and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information. Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Cardiol disclaims any intent or obligation to update or revise such forward-looking information, whether as a result of new information, future events or results or otherwise. Although Cardiol believes that the expectations reflected in the forward-looking information are reasonable, they do involve certain assumptions, risks, and uncertainties and are not (and should not be considered to be) guarantees of future performance. It is important that each person reviewing this news release understands the significant risks attendant to the operations of Cardiol.

Click here to connect with Cardiol Therapeutics Inc. (TSX:CRDL) for an Investor Presentation.

Source

Read more from the original source:
Cardiol Announces Study Demonstrating Its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart | INN - Investing News Network

Nanomechanical Testing Market Introduction

Nanomechanical testing involves the technique and equipment used to study the fundamental mechanical properties of materials at the level of nanometers. The testing of mechanical properties of nanomaterials forms the scientific foundation for nanotechnology.

Get Sample Copy of the Report @https://www.tmrresearch.com/sample/sample?flag=B&rep_id=5124

Nanomechanical testing equipment and methods are used to test the effectiveness of nanomaterials for specific applications by thoroughly analyzing the thermal, elastic, and kinetic properties of nanostructures. The testing equipment and techniques is finding usage in the production of nanopowders, nanotubes, carbon nanotubes, nanocoatings, nanocomposite materials, nanorods, nanowires, and other nanostructures. Nanotechnology-based components are finding widespread adoption in an assortment of industries and the demand for these elements is estimated to remain robust in the foreseeable future. A surge in the demand for nanotechnology-based components in an array of industrial applications is expected to fuel nanomechanical testing market growth with the market generating revenues of approximately US$ 280 million in 2018.

Nanomechanical Testing Market Dynamics

High-Temperature Nanomaterial Testing to Remain a Vital Revenue Pocket

With nanotechnology being a relatively newer field of interest in an array of industries, it is necessary to analyze the mechanical properties of nanomaterials under harsh environmental conditions to ensure they impart effective performance in real-time conditions. Testing of nanomaterials under high temperature is gradually gaining traction, stemming from the burgeoning demand for nanocoatings in high-temperature applications such as aerospace engine component production, nuclear reactor cladding, and high-speed machining. Effective analysis of the mechanical properties of nanomaterials under extreme temperature conditions is necessary to ascertain the performance of these advanced materials. Nanomechanical testing of materials at high temperature requires the use of precise, accurate, and careful designing of equipment than the ones used for analysis of these materials at room temperature. The burgeoning demand for the development of high-precision nanomechanical testing equipment and techniques are estimated to contribute significantly to the market growth. Nanoindentation is gradually emerging as a popular nanomechanical testing procedure for effectively analyzing the mechanical properties of nanomaterials under high temperatures.

Breakthroughs in MEMS Development to Uphold Nanomechanical Testing Market Growth

MEMS or micro-electro-mechanical systems are miniaturized versions of mechanical or electro-mechanical components which can vary in size from one micron to several millimeters. These are nothing but miniature sensors, actuators, and microelectronics. Continuous innovation and research and development in MEMS production are aiding manufacturers to effectively use the devices in analyzing the mechanical and electrical properties of nanostructures.

Additionally, nanomechanical testing is also used for the production of effective MEMS designs and devices. Organizations are increasingly using nanoindentation in combination with other nanomechanical testing techniques for testing the fracture and stiffness resistance of MEMS structures. Further, nanomechanical testing is finding widespread usage in the assessment and optimization of MEMS device tribology which is central to measuring the performance, reliability, and efficiency of these devices. MEMS is expected to find extensive adoption in biotechnology, medicinal, communication, and sensing applications which, in turn, is likely to bolster nanomechanical testing market growth.

Request TOC of the Report @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=5124

Intensifying R&D in Structure Modification: Key Determinant of Market Success

Controlling the structure of conventional materials while their modification to produce relevant and desired performance results is gradually gaining traction in an assortment of industries such as construction, semiconductor manufacturing, and electronics. With increasing microstructure complexity and growing demand for thinner, flexible, and smaller nanomaterials, the requirement for efficient classification techniques to measure the impact of changes on the overall mechanical properties of the structure is on the rise. Accelerating development and investments in material technology is expected to bolster nanomechanical testing market proliferation.

Environmental Safety and Human Health Concerns Surrounding Nanomaterials to Stifle Market Growth

A rapid rise in the uptake of nanomaterial in an assortment of industries is causing an increasing concentration of nanomaterials to enter the environment and even the human body. Increasing concentration of nanomaterial in the environment has been found out to have an adverse impact on small fish, algae, bacteria, and other crustaceans, a factor which could potentially create an imbalance in the ecosystem. The lack of effective techniques for measuring and defining the adverse impact of nanomaterials on human health and environment is further raising concerns about the growing use of the material in industries. These factors are expected to dampen nanomechanical testing market growth as administrations around the world are increasingly contemplating to implement stringent guidelines on the manufacturing and disposing of nanostructures.

Nanomechanical Testing Market Notable Highlights

Other leading players operating in the nanomechanical testing market are Micro Materials Limited, Testometric Co. Ltd., Quad Group Inc., Illinois Tool Works Inc., MTS Systems Corporation, Nanomechanics Inc., and Biomomentum Inc.

Nanomechanical Testing Market Segmentation

On the basis of offerings, the nanomechanical testing market can be segmented into:

Based on the end-use application, the nanomechanical testing market can be segmented into:

On the basis of instrument type, the nanomechanical testing market can be segmented into:

Follow this link:
Nanomechanical Testing Market to Witness Comprehensive Growth by 2028 - Science In Me

Nanotechnology in Medical Applications Market is a comprehensive report on the global market provides in-depth insight into the industry covering all the important parameters and analyzes that provide qualitative insight into the factors that affect Global Nanotechnology in Medical Applications Market growth. Includes all regions and countries in the world that show regional development status including market size.

Global Nanotechnology in Medical Applications Market research report has published by QY Reports and it is an effective data source for the readers. It offers widespread information on the Global Nanotechnology in Medical Applications Market. The purpose of this study is to define the overview of the global market with respect to market size, shares, sales patterns, and pricing structures. Primary and secondary research refer collect the desired data of the target market.

Ask for Sample Copy of This Report: https://www.qyreports.com/request-sample/?report-id=65147

Top Key Players Included in This Report:

Stryker Corporation (U.S.),3M Company (U.S.),St. Jude Medical Inc.(U.S.),PerkinElmer Inc. (U.S.).

The research objectives of this report are as follows:

Get Discount on This Report: https://www.qyreports.com/ask-for-discount/?report-id=65147

The report also summarized the high revenue generated with market facts and figures across regions such as North America, Japan, Europe, Asia and India. We focus on the key issues needed to have a positive impact on the market, such as policy, international trade, and speculation and supply demand in the Global Nanotechnology in Medical Applications Market.

This market research report on the Global Nanotechnology in Medical Applications Market is a comprehensive study of industry-specific frameworks, industry-strength drivers and manacles. Over the next seven years, we will provide market forecasts for the future. The study also provides markets for sectors such as end users, industries and size.

The report also covers in-depth explanations, competitive scenarios, and a broad product portfolio with a broad product portfolio of key players in Global Nanotechnology in Medical Applications Market and SWOT analysis adopted by competitors. This report provides Porter analysis, PESTEL analysis and market appeal to help you better understand macro and microscopic market scenarios.

If You Have Any Query, Ask Our Experts: https://www.qyreports.com/enquiry-before-buying/?report-id=65147

Table of Contents:

Chapter 1: Global Nanotechnology in Medical Applications Market OverviewChapter 2: Global Economic Impact on IndustryChapter 3: Market Competition by ManufacturersChapter 4: Production, Revenue (Value) by RegionChapter 5: Supply (Production), Consumption, Export, Import by RegionsChapter 6: Production, Revenue (Value), Price Trend by TypeChapter 7: Global Nanotechnology in Medical Applications Market Analysis by ApplicationChapter 8: Manufacturing Cost AnalysisChapter 9: Industrial Chain, Sourcing Strategy and Downstream BuyersChapter 10: Marketing Strategy Analysis, Distributors/TradersChapter 11: Market Effect Factors AnalysisChapter 12: Global Nanotechnology in Medical Applications Market Forecast

About Us Qyreports:

We at, Qyreports, a leading market research report published accommodate more than 4,000 celebrated clients worldwide putting them at advantage in todays competitive world with our understanding of research. Our list of customers includes prestigious Chinese companies, multinational companies, SMEs and private equity firms whom we have helped grow and sustain with our fact-based research. Our business study covers a market size of over 30 industries offering unfailing insights into the analysis to reimagine your business. We specialize in forecasts needed for investing in a new project, to revolutionize your business, to become more customer centric and improve the quality of output.

Contact:

QYReports

Jones John

(Sales Manager)

204, Professional Centre,

7950 NW 53rd Street, Miami, Florida 33166

+1-510-560-6005

[emailprotected]

http://www.qyreports.com

Read the original here:
Unexpected Growth in Nanotechnology in Medical Applications Market 2020 Report Outlining the Current State of the Market by 2020-2027 Along with Key...

Nanotechnology in Medical Devices Market report brings into light key market dynamics of the sector. It gives an in-depth knowledge on what the recent developments are, product launches are, while also keeping the track for recent acquisitions, mergers, joint ventures and competitive research in the global market industry. This report is intended to help the readers develop a practical and intelligent approach to market dynamics and exploit opportunities. The Nanotechnology in Medical Devices Market report is a professional yet exhaustive study on the current as well as future state for the market. This report analyzes the status and future forecast involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast in the major regions of the world.

Nanotechnology in medical devices market is expected to reach a market value of USD 20.52 billion by 2027 growing with the CAGR of 11.9% in the forecast period of 2020-2027. The increasing support of the government in the provision on advanced technology has been directly impacting the growth of nanotechnology in medical devices market.

Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nanotechnology-in-medical-devices-market&pm

Increasing geriatric population along with rising occurrences of diseases across the globe and growing adoption and need of high and advanced technology for the treatment of chronic diseases will accelerate the growth of the nanotechnology in medical devices market in the forecast period of 20202-2027. Rising number of applications from the emerging countries and advancement to technology for rich mid to late stage product pipeline will further create new opportunities for the growth of the market in the above mentioned forecast period.

Strict rules and regulations that will consume time in product approval and increasing process of nanotechnology based medical devices will hamper the growth of the market in the forecast period of 2020-2027.

Competitive Landscape and Nanotechnology in Medical Devices Market Share Analysis

Nanotechnology in medical devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to nanotechnology in medical devices market.

The major players covered in the nanotechnology in medical devices market report are 3M, Dentsply Sirona., Thermo Fisher Scientific Inc., PerkinElmer Inc, GENERAL ELECTRIC, Ferro Corporation, Eppendorf AG, Greiner Bio One International GmbH, ZELLMECHANIK DRESDEN, TV Rheinland, Medtronic, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, Demant A/S, Cochlear Ltd., Sonova, MED-EL, DEKRA, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Global Nanotechnology in Medical Devices Market Scope and Market Size

Nanotechnology in medical devices market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on product, the nanotechnology in medical devices market is segmented into active implantable devices, biochips, implantable materials, medical textiles and wound dressings, others. Active implantable devices have been segmented into cardiac rhythm management devices, hearing aid devices and retinal implants. Biochips have been further segmented into DNA microarrays and lab-on-chip. Implantable materials have been further segmented into dental restorative materials and bone substitute materials.Nanotechnology in medical devices market has also been segmented on the basis of applications into therapeutic applications, diagnostic applications and research applications.

Nanotechnology in Medical Devices Market Country Level Analysis

Nanotechnology in medical devices market is analysed and market size insights and trends are provided by country, product and application as referenced above.

The countries covered in the nanotechnology in medical devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nanotechnology in medical devices market because of prevalence of majority of nanotechnology based medical devices players and increasing government initiatives, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 because of increasing geriatric population, international research collaboration and increasing investment in research and development of nanotechnology.

The country section of the nanotechnology in medical devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

For More Insights Get FREE Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-nanotechnology-in-medical-devices-market&pm

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Nanotechnology in medical devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nanotechnology in medical devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nanotechnology in medical devices market. The data is available for historic period 2010 to 2018.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @ [emailprotected]

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Read the rest here:
Nanotechnology in Medical Devices Market 2020 is Slated to Witness Tremendous Growth in Coming Years | Leading Players 3M, Dentsply Sirona., Thermo...

AUSTIN, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:PSTV) (the Company), today announced financial and business results for its Second Quarter Fiscal Year 2020 ended June 30, 2020.

Q2 2020 net loss was $1.8 million, or $0.45 per share, including payments to NanoTx LLC of $0.78 million. Net cash used in operating activities for the six months ended June 30, 2020 was approximately $2.9 million. Plus Therapeutics ended Q2 2020 with approximately $9.3 million of cash and cash equivalents.

The Plus Therapeutics portfolio has three clinical-stage injectable drugs being developed on a unique nanotechnology platform designed to provide patient benefits through improved formulation and delivery innovation. The Company believes the platform can enable significant potential enhancements of safety, efficacy and convenience for oncology patients and their health providers compared to current standards of care.

The lead investigational drug in the Companys licensed radiotherapeutic portfolio is Rhenium NanoLiposomes (RNL), a nanoliposome-encapsulated radionuclide for several cancer targets. Initially being developed for the treatment of recurrent glioblastoma, RNL is being evaluated in the U.S. NIH/NCI-supported, multi-center ReSPECT Phase 1 dose-finding clinical trial (NCT01906385). RNL is designed to safely, effectively, and conveniently deliver a very high dose of radiation directly into the brain tumor that is up to 25 times greater than that currently being given to recurrent glioblastoma patients using external beam radiation therapy.

H2 2020 Business Expansion Outlook

The first half of Fiscal Year 2020 marked the successful implementation of the Companys refined development focus, initial pipeline expansion and optimized cost structure. In the second half of Fiscal Year 2020, the Company intends to focus on a number of additional business objectives and potential milestones:

Following the close of our most recent in-licensing transaction, we have made steady progress in expediting the ReSPECT trial, said Dr. Marc Hedrick, President and Chief Executive Officer of Plus Therapeutics. The second half of 2020 includes the prospect of further significant advancement for our RNL program-- and for the Company. We believe RNL has the potential of improving brain tumor therapy and that of other difficult to treat radiosensitive tumors.

Q2 2020 Financial Highlights

Investor Call Today at 5 p.m. EDT

The Company plans to hold a conference call and live audio webcast today at 5:00 PM Eastern Time to discuss its financial results and provide a general business update.

About Plus Therapeutics, Inc.

Plus Therapeutics (Nasdaq: PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets. Central to the Companys drug development is a unique nanotechnology platform designed to reformulate, deliver and commercialize multiple drugs targeting rare cancers and other diseases. The platform is designed to facilitate new delivery approaches and/or formulations of safe and effective, injectable drugs, potentially enhancing the safety, efficacy and convenience for patients and healthcare providers. More information may be found atwww.plustherapeutics.com and http://www.respect-trials.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains statements that may be deemed forward-looking statements within the meaning of U.S. securities laws. All statements in this press release other than statements of historical fact are forward-looking statements. These forward-looking statements may be identified by future verbs, as well as terms such as will, believe, plan, can, enable, design, intend, potential, expect, estimate, project, prospect, target, focus, anticipate, could, should, and similar expressions or the negatives thereof. Such statements are based upon certain assumptions and assessments made by management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. These statements include, without limitation, statements regarding the following: the design and potential of the Plus Therapeutics portfolio to reformulate, deliver and commercialize multiple novel, proprietary drugs targeting rare cancers and other diseases and to facilitate new delivery approaches and/or formulations of safe and effective, injectable drugs; the Companys belief as to the platforms capacity to leverage new delivery approaches and/or formulations to enable significant potential enhancements of safety, efficacy and convenience for patients and healthcare providers; the potential of the Companys portfolio generally, and the potential of RNL to safely and effectively deliver a dose of radiation directly to the tumor up to 25 times greater than that currently being given to patients using external beam radiation therapy; the Companys belief as to the potential of RNL to improve brain tumor therapy and that of other difficult to treat radiosensitive tumors; the timing, status, outcome, and anticipated expansion of clinical trials for RNL, including the planned initiation of an additional Phase 1 study and enrollment at additional sites, and the anticipated timing thereof; the Companys business expansion outlook for the second half of 2020, including its intended focus on certain additional business expansion milestones; the Companys expectations regarding the progress and prospect of advancement for the Company, RNL, and the Companys portfolio during the second half of 2020; and the potential impact of the COVID-19 pandemic on the Company and its clinical programs, operating results, and financial condition. The forward-looking statements included in this press release are subject to a number of risks and uncertainties that may cause actual results to differ materially from those discussed in such forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that the Company is not able to successfully develop product candidates that can leverage the U.S. FDAs accelerated regulatory pathways; the early stage of the Companys product candidates and therapies, the results of its research and development activities, including uncertainties relating to the clinical trials of its product candidates and therapies; the Companys history of losses; the Companys need for, and ability to raise, additional cash or obtain other sources of funding; the Companys ability to: (a) obtain and maintain regulatory approvals, (b) continue as a going concern, (c) remain listed on the Nasdaq Capital Market, (d) to obtain or maintain sufficient levels of reimbursement for its tests, and (d) to repay or refinance some or all of its outstanding indebtedness; the outcome of the Companys partnering/licensing efforts; market and economic conditions; the impact of the COVID-19 pandemic on the Company and the effectiveness of the efforts it has taken or may take in the future in response thereto; and additional risks described under the heading Risk Factors in the Companys Securities and Exchange Commission filings, including in the Companys annual and quarterly reports. There may be events in the future that the Company is unable to predict, or over which it has no control, and its business, financial condition, results of operations and prospects may change in the future. The Company assumes no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made unless the Company has an obligation under U.S. federal securities laws to do so.

Contact:Plus Therapeutics, Inc.Andrew SimsVP Chief Financial Officer, Investor RelationsPhone: +1.619.333.4150Email:ir@plustherapeutics.comCorporate Website:plustherapeutics.comClinical Website: respect-trials.com

Excerpt from:
Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results - BioSpace

In 1959, physicist Richard Feynman predicted a future in which scientists would, by manipulating atoms and molecules, be able to build materials and structures of higher strength, lighter weight, increased control of the light spectrum, and greater chemical reactivity.

Everything of a physical nature human beings, plants, minerals, air is composed of combinations of atoms and molecules bound together either by shape or electronic charge. Manipulating atoms on a nano-scale would theoreticallyallow humans to reproduce everything from diamonds to food.

While the benefits of such technology are virtually countless, it has created considerable concern among some that molecular manipulation may unwittingly bring more problems than solutions up to, and including, human extinction. Organizations such as Friends of the Earthof Australia, Individuals Tending Toward Savagery in Mexico, and the Organic Consumers Association in America actively oppose any further development of nano-scale projects.

Nanotechnology is the science that deals with the manipulation of matter on an atomic, molecular, and supramolecular scale in other words, much smaller than what the naked eye can see. Each nanometer is one billionth of a meter approximately the length a fingernail grows in one second. To put that in perspective, a human hair is roughly 80,000 to 100,000 nanometers wide, a red blood cell is 2,500 nanometers, and a strand of human DNA is 2.5 nanometers in diameter.

It is only through the development of extraordinary precision instruments, such as the scanning tunneling microscope and the atomic force microscope, that nanotechnology has become possible. Its promise and risk arise from our growing understanding of quantum physics, which deals with ultra-small objects. Surprisingly, the behavior of substances on a nanoscale is often contrary to its properties on a larger scale.

For example, substances in bulk form that cant carry an electric charge insulators may become semiconductors on a nano level, just as melting points and other physical properties may change. An aluminum Coke can ground down into a powder of 20 to 30 nanometers may spontaneously ignite in air a property that makes it a rocket fuelcatalyst. Similarly, both a diamond and the graphite in a pencil are made from carbon, but they have vastly different properties due to the way the carbon atoms bond.

As science has expanded in the nano field, so has the terminology. Here are some basic definitions:

According to the Society of Toxicology, advances in nanotechnology are already producing a variety of new materials. They are also adapting old materials, such as carbon, thus giving them great potential to improve consumer and industrial products, address critical energy needs, enhance security systems, and improve the medical field.

Carbon nanotubes imagine a sheet of carbon atoms rolled up appear now in consumer products like tennis racquets and golf clubs. They exhibit 200 times the strength and five times the elasticity of steel, five times the electrical conductivity of copper, and half the density of aluminum. In addition, they do not rust, degrade from radiation, or expand or contract with temperature change. In this regard, the appeal of their application in such products as automobiles and airplanes becomes quite obvious.

The Project on Emerging Nanotechnologies at Virginia Tech lists more than 1,790 existing consumer products that are nano-enabled, including cotton sheets, degreasers, golf shafts, paint, and cosmetics. Some scientists have even predicted that solar cells can eventually be developed with such durability and at such a low cost as to allow their use in roofing, sidewalks, and roads making way for a nonpolluting, abundant, and inexpensive energy supply.

Specific examples of existing products using nanotechnology include the following:

As projected by the Foresight Institute, the everyday benefits of an increased availability of nanofactories would include the following:

Even proponents of nanotechnology, such as Burch and Drexler, recognize its potential to harm and possibly annihilate the human race if the technology is uncontrolled or misdirected. These potentially harmful effects include the following:

Steve Jurvetson, managing director of the venture capital firm Draper Fisher Jurvetson, claims that the future of nanotechnology is not a matter of if, but rather when. Josh Wolfe, co-founder of Lux Capital and editor of the Forbes/Wolfe Nanotech Report agrees, saying that everything clothing, food, cars, housing, medicine, communication devices, the air we breathe and the water we drink will undergo profound and fundamental change. And as a result, so will the socio and economic structure of the world.

Will nanotechnology be the philosophers stone capable of making every wish come true, or the opening of Pandoras box, unleashing unimaginable hardship and horrors on human life as we know it?

Visit link:
What Is Nanotechnology - Examples, Future Applications & Risks

The competitive landscape of the global nanotechnology drug delivery market is largely consolidated, with a small number of companies accounting for dominant share in the global market in 2014, observes Transparency Market Research in a recent report. However, the scenario is steadily changing as a number of new pharmaceutical companies foray into the nanotechnology drug delivery space in the lookout for innovative, more effective drug delivery techniques. The rising sums that new companies are investing in research and development in this field are allowing for a rise in R&D activities, helping the market expand at a steady pace.

Collaborations among leading pharmaceutical companies and technology developers is a trend that has picked pace in the market in the past few years. This is enabling massive improvements in clinical models used for evaluating the efficiency of nanomedicines. A number of companies are also focusing on the development of nanomedicines for the treatment of a variety of cancers. Some of the leading companies in the market are Amgen, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Novartis AG, and AbbVie, Inc.

Request Brochure of Report https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1822

The report predicts that the global nanotechnology drug delivery market will expand at an excellent 12.5% CAGR from 2015 and 2023. If the predictions hold true, the market will rise from a valuation of US$ 4.1bn in 2014 to US$11.9 bn by 2023.

North America to Remain Most Lucrative Regional Market

Of the key applications of nanotechnology drug delivery examined in the report, the oncology segment emerged as the contributor in terms of revenue in 2014. Demand for nanotechnology drug delivery is expected to be the highest in the oncology sector over the reports forecast period as well owing to the massive rise in prevalence of a number of cancers and the high demand for effective treatment methods for cancers across the globe.

Request for Analysis of COVID19 Impact on Nanotechnology Drug Delivery Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1822

Geography-wise, the market in North America accounted for the dominant share in the overall market in 2014. The region boasts a vast number of some of the worlds leading pharmaceutical companies, technology developers, and research institutions. Moreover, the massive rise in incidence rate of a number of chronic diseases has compelled governments in developed countries in the region to encourage R&D activities and the development of more effective ways of treating common diseases.

Vast Rise in R&D Activities Enable Development of New Drug Delivery Models

The global market for nanotechnology drug delivery is chiefly driven due to a host of factors, including advancements in nanotechnology, which have revolutionized the field of drug delivery, the rising prevalence of infectious diseases, a variety of cancers, and numerous chronic ailments, and the rising demand for novel and more effective drug delivery systems. The vast rise in research activities in the field of nanotechnology, which has enabled the discovery of several new and more effective varieties of imaging and therapeutic agents and thus the development of more reliable diagnostics and therapeutic options, are also spelling growth for the market.

Buy Nanotechnology Drug Delivery Market Report https://www.transparencymarketresearch.com/checkout.php?rep_id=1822&ltype=S

However, the markets growth is limited by a certain degree owing to the uncertain regulatory scenario pertaining to the approval of nanotechnology products on a global front and the high cost of nanomedicines. The high cost of nanomedicines is especially a big challenge for the market when it comes to targeting emerging markets with cost-conscious consumers.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Read more here:
Nanotechnology Drug Delivery Market is Projected to Reach US$ 118,527.2 Mn by 2023 - Science Examiner

Nanotechnology is poised to revolutionize the diagnosis and treatment of patients with type 1 diabetes.

According to the WHO, in 2016, an estimated 1.6 million deaths were directly caused by diabetes. It is a chronic disease that occurs when the body is unable to produce or process a hormone called insulin, which helps regulate blood sugar levels.

Of the three major types, type 1 diabetes has proven to be the most problematic in terms of providing patients with a timely diagnosis, as patients may be asymptomatic for long periods of time with a sudden onset of symptoms well into the diseases progression.

Currently, type 1 diabetes can be diagnosed at any age, but it is mostly found in children and adolescents. Once diagnosed, patients also have a high risk of diabetes-related complications, as well as other autoimmune diseases, such as hashimotos thyroiditis or celiac disease. Therefore, early diagnosis and treatment could prevent the progression of type 1 diabetes.

At present, the diagnosis of type 1 diabetes depends on the detection of blood glucose levels and islet autoantibodies, which are markers that appear when insulin producing islet cells clusters of hormone producing cells in the pancreas are damaged. But the function of the patients cells have likely already been severely damaged by the time they receive a diagnosis.

As more and more people suffer from type 1 diabetes of the 422 million people worldwide diagnosed with diabetes in 2016, roughly 5% were categorized as type 1 the importance of early diagnosis and the urgency of effective treatments becomes ever more important. However, recent medical methods for the early diagnosis of type 1 diabetes are still limited. So, its important to develop new methods for early diagnosis and treatment.

Nanomedicine is an emerging field and provides a promising and more effective alternative to diagnose type 1 diabetes, and stands to revolutionize treatment for patients. Experts in this field, Dr. Yuanzeng Min from the School of Chemistry and Material Science at the University of Science and Technology of China (USTC) and Dr. Jianping Weng, a clinician from the First Affiliated Hospital of USTC discuss the findings in a recent reviewpublished in WIREs Nanomedicine and Nanobiotechnology.

Magnetic resonance imaging (MRI) has in itself revolutionized imaging in medicine. It takes advantage of powerful magnets to make a detailed internal picture of the body and helps doctors diagnose otherwise unseen disease or injury. To improve this technique and make it more suitable to diagnosing patients with type 1 diabetes, scientists have explored using common biomarkers of the disease, such as inflammation, and enhancing physicians ability to detect them in MRI analysis using helper materials. In this sense, nanomaterials have been shown great promise in facilitating the accumulation of imaging substrates at the targeted site, thus improving the quality of MRI imaging and the accuracy of diagnosis.

An excellent example of this is the clinical use of the nanoparticle ferumoxtran-10 or ferumoxytol. In clinical studies, there was an observed increase in pancreatic accumulation of this imaging nanoparticle in inflamed islets of type 1 diabetes patients in comparison to a healthy control group. This method is non-invasive, and the imaging materials are readily metabolized by the body without harmful side effects. This technique has been ground-breaking in visualizing insulitis, an inflammatory lesion and an early stage marker of type 1 diabetes.

Type 1 diabetes is classified as an autoimmune disease in which insulin-producing cells are destroyed by the bodys own immune system, and is affected by a number of factors, such as genetics, environment and metabolism, among others. The downregulation of the overactive immune cells that kill the insulin-producing cells has been gathering more and more attention in the medical and research community.

Studies have shown that nanoparticles have the beneficial characteristics of high drug loading and are capable of being targeted to a specific location in the body, minimizing harmful side effects usually observed in these types of therapies. Scientists have used loaded nanoparticles to carry antigenic peptides or pMHC (peptide major histocompatibility complex) to suppress the bodys immune response so that the immune cells no longer attack cells. Research has also explored encapsulating cytokines or other synthesized molecules to modulate the immune system into the nanoparticles, which could be locally administered along with modulating immune cells, such as T cells or APCs (antigen presenting cells).

Significant progress in the development of sophisticated nanotechnologies has also been seen in the past 10 years for immunotherapy and islet transplantation in type 1 diabetes. Nanotechnology has played a significant role in islet transplantation by encapsulating healthy cells with biomaterials as most of the insulin-producing cells are destroyed by the patients own immune system. The biomaterials also protect the transplanted cells from immune exclusion. In addition to avoiding a deleterious host response, encapsulated islets must receive an adequate nutrient supply and positive extracellular cues in order to survive and functionin vivo.Thus, while using nanotechnology to encapsulate cells, it alsorequires as little interference as possible with the generation of new blood vessels in the encapsulation. This is usually achieved by improving the mechanical rigidity, charge distribution, morphology, and other related parameters of the nanomaterials.

While great strides have been made, limitations in the application of nanotechnology in diagnosis and treatment of type 1 diabetes remain. For example, some nanoparticles are not specifically target islets, their production process can be complicated, and the cost is high. However, their application in this area of medicine has only just begun, and we are beginning to see the benefits of this research in clinical trials.

With research in type 1 diabetes and the development of nanotechnology, these problems will hopefully one day be solved. We believe that in the next 10-20 years there will be high chance of this type of therapy used regularly in the clinical diagnosis and treatment oftype 1 diabetes patients.

Written by: Yuanzeng Min and Jianping Weng

Reference: Wen Pan, et al. Nanotechnologys application in Type 1 diabetes. WIREs Nanomedicine and Nanobiotechnology (2020). DOI: 10.1002/wnan.1645

Visit link:
Earlier diagnosis and better treatment for type 1 diabetes - Advanced Science News

A federal grand jury has indicted a former Harvard nanotechnology expert on two charges of making false statements for his alleged yearslong work with the Chinese government while receiving at least $15 million in federal grants.

Dr. Charles Lieber, 61, will be arraigned in U.S. District Court at a date to be determined, and was initially arrested in January before being released on a $1 million cash bond.

Feds say Wuhan University of Technology paid Lieber $50,000 a month, approximately $158,000 in living expenses and $1.5 million to establish a research laboratory in exchange for working on behalf of the university for not less than nine months a year beginning in 2011.

Lieber also allegedly lied to Harvard, the Department of Defense and the National Institutes of Health about his work with Chinas Thousand Talents program, labeled by feds as an organization rewarding proprietary espionage.

The former chairman of the Department of Chemistry and Chemical Biology at Harvard, who was placed on paid administrative leave, was awarded at least $15 million in grants from the DOD and NIH while collaborating with China, according to feds.

An attorney for Lieber did not respond to a Herald inquiry Tuesday.

Liebers indictment comes after a string of Chinese espionage prosecutions earlier this year in Boston, including two Chinese nationals and researchers also accused of working with their own government.

U.S. Attorney Andrew Lelling said in February his office has leads on Chinese espionage cases in Boston, and also said universities have grown as allies to combat espionage attempts.

Zaosong Zheng, who was allegedly captured at Boston Logan International Airport with stolen vials of cancer research from a local hospital lab, has a federal court hearing scheduled Friday.

Yanqing Ye, an alleged lieutenant in the Peoples Liberation Army accused of researching the U.S. military while she was sponsored by Boston University to study here, is still wanted by the FBI.

See the original post here:
Harvard scientist indicted on charges of lying about Chinese research, financial ties - Boston Herald

Flow of lithium ions into and out of alloy battery anodes has long been a limiting factor in how much energy batteries could hold using conventional materials. Too much ion flow causes anode materials to swell and then shrink during charge-discharge cycles, causing mechanical degradation that shortens battery life. To address that issue, researchers have previously developed hollow yolk-shell nanoparticles that accommodate the volume change caused by ion flow, but fabricating them has been complex and costly.

Now, researchers at Georgia Tech, with colleagues at ETH Zrich and Oak Ridge National Laboratory, have discovered that sufficiently small antimony nanocrystals spontaneously form uniform voids on the removal of lithium, which are then reversibly filled and vacated during cycling, allowing more ion flow without damaging the anodes. A paper on their work is published in Nature Nanotechnology.

An electron microscope image shows the antimony nanoparticles used to study the spontaneous formation of nanoscale hollow electrodes for use in batteries. (Credit: Matthew Boebinger)

Intentionally engineering hollow nanomaterials has been done for a while now, and it is a promising approach for improving the lifetime and stability of batteries with high energy density. The problem has been that directly synthesizing these hollow nanostructures at the large scales needed for commercial applications is challenging and expensive. Our discovery could offer an easier, streamlined process that could lead to improved performance in a way that is similar to the intentionally engineered hollow structures.

Matthew McDowell, corresponding author

The researchers made their discovery using a high-resolution electron microscope that allowed them to directly visualize battery reactions as they occur at the nanoscale.

The team also used modeling to create a theoretical framework for understanding why the nanoparticles spontaneously hollowinstead of shrinkingduring removal of lithium from the battery.

The ability to form and reversibly fill hollow particles during battery cycling occurs only in oxide-coated antimony nanocrystals that are less than approximately 30 nanometers in diameter. The research team found that the behavior arises from a resilient native oxide layer that allows for initial expansion during lithiationflow of ions into the anodebut mechanically prevents shrinkage as antimony forms voids during the removal of ions, a process known as delithiation.

The finding was a bit of a surprise because earlier work on related materials had been performed on larger particles, which expand and shrink instead of forming hollow structures.

Antimony is relatively expensive and not currently used in commercial battery electrodes. But McDowell believes the spontaneous hollowing may also occur in less costly related materials such as tin. Next steps would include testing other materials and mapping a pathway to commercial scale-up.

It would be interesting to test other materials to see if they transform according to a similar hollowing mechanism. This could expand the range of materials available for use in batteries. The small test batteries we fabricated showed promising charge-discharge performance, so we would like to evaluate the materials in larger batteries.

Matthew McDowell

Though they may be costly, the self-hollowing antimony nanocrystals have another interesting property: they could also be used in sodium-ion and potassium-ion batteries, emerging systems for which much more research must be done.

This work was performed at the Georgia Tech Materials Characterization Facility and the Institute for Electronics and Nanotechnology, a member of the National Nanotechnology Coordinated Infrastructure, which is supported by the National Science Foundation (Grant ECCS-1542174). Support also came from the Department of Energy Office of Science Graduate Student Research Program for research performed at Oak Ridge National Laboratory.

A portion of this research was conducted at the Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility. Support was also provided by a Sloan Research Fellowship in Chemistry from the Alfred P. Sloan Foundation and by the Swiss National Science foundation via an Ambizione Fellowship (no. 161249). The content is solely the responsibility of the authors and does not necessarily represent the official views of the sponsoring organizations.

Resources

Matthew G. Boebinger, et al. (2020) Spontaneous and reversible hollowing of alloy anode nanocrystals for stable battery cycling Nature Nanotechnology doi: 10.1038/s41565-020-0690-9

See the original post here:
Spontaneous formation of hollow structures in alloy anode crystals can improve battery stability - Green Car Congress

Global Nanotechnology in Medical Equipment Market Growth (Status and Outlook) 2020-2025 organized by researchers at MarketsandResearch.biz presents a detailed diagram of the market in terms of current and future trends driving the profit pattern. The report includes informative data figures and key insights regarding the market components such as market size, market share, market segmentation, significant growth drivers, and market competition. The report outlines expected business up-downs, different aspects impacting economic cycles in the market, demand, changing customer sentiments, key companies operating in the global Nanotechnology in Medical Equipment market, and regional landscape with the help of statistics, diagrams, charts, and graphs. It provides a SWOT analysis of the competitive landscape of the market.

Then the report covers factors such as industry value chain, key consumption trends, recent patterns of customer behaviors, overall spending capacity analysis, market expansion rate, etc. This study categorizes the global Nanotechnology in Medical Equipment breakdown data by manufacturers, region, type, and applications, also analyzes the market drivers, opportunities, and challenges. There is a section featuring the essential data gathered through Industry specialists and key authorities of profiled organizations. Leading players are considered relying upon their organization profile, item portfolio, limit, item/benefit value, deals, and cost/benefit.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/59721

NOTE: This report takes into account the current and future impacts of COVID-19 on this industry and offers you an in-dept analysis of Nanotechnology in Medical Equipment market.

Key manufacturers analysis: Stryker Corporation, AAP Implantate AG, 3M, Thermo Fisher Scientific, PerkinElmer, Inc., Abbott, Dentsply International, Starkey Hearing Technologies, Mitsui Chemicals, Inc., Smith + Nephew,

On the basis of product types, the global market is classified into: Active Implantable Medical Equipments, Biochip, Portable Material,

On the basis of end-users, the global market is classified into: Treatment Using, Diagnostic Using, Research Using,

This Report Enfolds Following Market Aspects:

Key players strategic initiatives and competitive developments such as joint ventures, mergers, and new product launches in the market are taken into consideration. Nanotechnology in Medical Equipment providers, research and consulting firms, government and research organizations, and associations and industry bodies are the target audiences of this market research report. Forecast estimates are given for regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end-use industry trends and dynamics, and capacity.

The global Nanotechnology in Medical Equipment market report also analyzes the major geographic regions as well as the major countries in these regions. The regions and countries covered in the study include: Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries)

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/59721/global-nanotechnology-in-medical-equipment-market-growth-status-and-outlook-2020-2025

Report Answers Following Questions:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketsandresearch.biz

View original post here:
Global Nanotechnology in Medical Equipment Market 2020 SWOT Analysis & Key Business Strategies by Leading Industry Players and Forecast 2025 - 3rd...

AUSTIN, Texas The 5G revolution has begun, and the first lines of phones that can access the next generation of wireless speeds have already hit the shelves. Researchers at The University of Texas at Austin and the University of Lille in France have built a new component that will more efficiently allow access to the highest 5G frequencies in a way that increases devices battery life and speeds up how quickly we can do things like stream high-definition media.

Smartphones are loaded with switches that perform a number of duties. One major task is jumping between networks and spectrum frequencies: 4G, Wi-Fi, LTE, Bluetooth, etc. The current radio-frequency (RF) switches that perform this task are always running, consuming precious processing power and battery life.

The switch we have developed is more than 50 times more energy efficient compared to what is used today, said Deji Akinwande, a professor in the Cockrell School of Engineerings Department of Electrical and Computer Engineering who led the research. It can transmit an HDTV stream at a 100 gigahertz frequency, and that is unheard of in broadband switch technology.

Akinwande and his research team published their findings today in the journal Nature Electronics.

It has become clear that the existing switches consume significant amounts of power, Akinwande said. And that power consumed is useless power.

The new switches stay off, saving battery life for other processes, unless they are actively helping a device jump between networks. They have also shown the ability to transmit data well above the baseline for 5G-level speeds.

The U.S. Defense Advanced Research Projects Agency (DARPA) has for years pushed for the development of near-zero-power RF switches. Prior researchers have found success on the low end of the 5G spectrum where speeds are slower but data can travel longer distances. But, this is the first switch that can function across the spectrum from the low-end gigahertz (GHz) frequencies to high-end terahertz (THz) frequencies that could someday be key to the development of 6G.

The UT teams switches use the nanomaterial hexagonal boron nitrite (hBN). It is an emerging nanomaterial from the same family as graphene, the so-called wonder material. The structure of the switch involves a single layer of boron and nitrogen atoms in a honeycomb pattern, which Akinwande said is almost 1 million times thinner than human hair, sandwiched between a pair of gold electrodes.

The impact of these switches extends beyond smartphones. Satellite systems, smart radios, reconfigurable communications, the internet of things and defense technology are all examples of other potential uses for the switches.

Radio-frequency switches are pervasive in military communication, connectivity and radar systems, said Dr. Pani Varanasi, division chief of the materials science program at the Army Research Office, an element of the U.S. Army Combat Capabilities Development Commands Army Research Laboratory that helped fund the project. These new switches could provide large performance advantage compared to existing components and can enable longer battery life for mobile communication, and advanced reconfigurable systems.

This research spun out of a previous project that created the thinnest memory device ever producedalso using hBN. Akinwande said sponsors encouraged the researchers to find other uses for the material, and that led them to pivot to RF switches.

The UT team includes electrical and computer engineering professor Jack Lee and graduate students Myungsoo Kim, Ruijing Ge and Xiaohan Wu. They worked with researchers at the University of Lilles Institute of Electronics, Microelectronics and Nanotechnology, led by Emiliano Pallecchi and Henri Happy.

The research was funded through grants from the U.S. Office of Naval Research, the Army Research Office, and an Engineering Research Center funded by the National Science Foundation. Fabrication of the switch was partly done at the Texas Nanofabrication Facility, and hBN samples were provided by Grolltex Inc.

Read this article:
New 5G Switches Mean Battery Life Improvements, Higher Bandwidth and Speeds - UT News | The University of Texas at Austin

Global Nanotechnology in Drug Delivery market report studies the market situation and outlook represents the global Nanotechnology in Drug Delivery market size (value and volume) and Share by companies, type, application, and region. The widespread Global Nanotechnology in Drug Delivery trends and opportunities are also taken into consideration in Nanotechnology in Drug Delivery industry study Nanotechnology in Drug Delivery Market report focus on the following section is to analyze the Nanotechnology in Drug Delivery industry by acceptance among various segments; the primary product types covered under the scope of the report.

MANUFACTURERScovered in this Nanotechnology in Drug Delivery market report:

Access PharmaceuticalsCamurusAlkermesAquanovaCelgeneCapsulution Pharma

GetFREESample Report @ https://www.reportspedia.com/report/life-sciences/global-nanotechnology-in-drug-delivery-market-2020-by-company,-regions,-type-and-application,-forecast-to-2025/55050 #request_sample

This Nanotechnology in Drug Delivery market report is a complete analysis of the Nanotechnology in Drug Delivery market based on primary and secondary in-depth analysis. The scope of the Nanotechnology in Drug Delivery market report includes global and regional sales, product consumption in terms of volume, and value. The global Nanotechnology in Drug Delivery market report provides an estimate of revenue, CAGR, and aggregate revenue. The collected knowledge about Nanotechnology in Drug Delivery global business is represented in the figures, tables, pie charts, and graphs.

On the basis of product eachTYPESprimarily split into:

Targeted DeliveryDrug Package

On the basis of product eachAPPLICATIONSprimarily split into:

CancerTumorOther

Market Primarily Focusing On Nanotechnology in Drug Delivery Market:

Ask for Discount @ https://www.reportspedia.com/discount_inquiry/discount/55050

Global Nanotechnology in Drug Delivery Market: Drivers and Restrains

The research report has incorporated the analysisof variousfactors that augment the markets growth. It establishes trends, restraints, and drivers that transmute the market in either a positive or negative manner. This section also provides the scopeof varioussegments and applicationswhich willpotentially influence the marketin thefuture. The detailed informationrelieson current trends and historic milestones. This section also provides an analysis ofthe quantityof sales aboutthe worldwide Nanotechnology in Drug Delivery market and also about each type from 2015 to 2025. This section mentionsthe quantityof sales by region from 2015 to 2025. Pricing analysis is includedwithin thereportconsistent witheach type from the year 2015 to 2025, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2025.

A thorough evaluation of the restrains includedwithin thereport portrays the contrast to driversand providesroom for strategic planning. Factors that overshadow the market growth are pivotal asthey willbe understoodto plandifferent bends for getting hold of the lucrative opportunities that are presentin theever-growing Nanotechnology in Drug Delivery market. Additionally, insights into market experts opinionsaretakento knowthe market better.

Global Nanotechnology in Drug Delivery Market: Segment Analysis

The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2025. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2025. Understanding the segments helps in identifying the importance of different factors that aid the Nanotechnology in Drug Delivery market growth.

Global Nanotechnology in Drug Delivery Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Nanotechnology in Drug Delivery report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2025. These analyses will help the readerto knowthe potential worth of investmentduring aparticular region.

Global Market: Competitive Landscape

This section of the report finds various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players arethat specialize incombat competitionwithin themarket.The greatreport providesa bigmicroscopiccheck outthe Nanotechnology in Drug Delivery market. The reader can categorize the footprints of the manufacturers by knowing aboutthe worldwiderevenue of manufacturers,the worldwideprice of manufacturers, and sales by producers during the forecast period of 2015 to 2019.

View Report TOC In detail @ https://www.reportspedia.com/report/life-sciences/global-nanotechnology-in-drug-delivery-market-2020-by-company,-regions,-type-and-application,-forecast-to-2025/55050 #table_of_contents

Original post:
Global Nanotechnology in Drug Delivery Market Size, Share, Growth Drivers, Regional Analysis and forecasts to 2025 - Cole of Duty

10x Technology 3M 3rd Millennium 3rdTech Bayer Material Science and Cortex

Global Nanotechnology Market: Competitive Landscape

This section of the report lists various major manufacturers in the market. The competitive analysis helps the reader understand the strategies and collaborations that players focus on in order to survive in the market. The reader can identify the players fingerprints by knowing the companys total sales, the companys total price, and its production by company over the 2020-2026 forecast period.

Global Nanotechnology Market: Regional Analysis

The report provides a thorough assessment of the growth and other aspects of the Nanotechnology market in key regions, including the United States, Canada, Italy, Russia, China, Japan, Germany, and the United Kingdom United Kingdom, South Korea, France, Taiwan, Southeast Asia, Mexico, India and Brazil, etc. The main regions covered by the report are North America, Europe, the Asia-Pacific region and Latin America.

The Nanotechnology market report was prepared after various factors determining regional growth, such as the economic, environmental, technological, social and political status of the region concerned, were observed and examined. The analysts examined sales, production, and manufacturer data for each region. This section analyzes sales and volume by region for the forecast period from 2020 to 2026. These analyzes help the reader understand the potential value of investments in a particular country / region.

We Offer up to 30% Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=15416&utm_source=COD&utm_medium=001

Key Benefits for Stakeholders:

The report provides an in-depth analysis of the size of the Nanotechnology world market, as well as recent trends and future estimates, in order to clarify the upcoming investment pockets.

The report provides data on key growth drivers, constraints and opportunities, as well as their impact assessment on the size of the Nanotechnology market.

Porters 5 Strength Rating shows how effective buyers and suppliers are in the industry.

The quantitative analysis of the Nanotechnology world industry from 2020 to 2026 is provided to determine the potential of the Nanotechnology market.

This Nanotechnology Market Report Answers To Your Following Questions:

Who are the main global players in this Nanotechnology market? What is the profile of your company, its product information, its contact details?

What was the status of the global market? What was the capacity, the production value, the cost and the profit of the market?

What are the forecasts of the global industry taking into account the capacity, the production and the value of production? How high is the cost and profit estimate? What will be the market share, supply, and consumption? What about imports and export?

What is market chain analysis by upstream raw materials and downstream industry?

Get Complete Report @ https://www.verifiedmarketresearch.com/product/nanotechnology-market/?utm_source=COD&utm_medium=001

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defence, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll Free: +1 (800)-7821768

Email: [emailprotected]

Tags: Nanotechnology Market Size, Nanotechnology Market Trends, Nanotechnology Market Growth, Nanotechnology Market Forecast, Nanotechnology Market Analysis

See the rest here:
Nanotechnology Market Growth Opportunities, Challenges, Key Companies, Drivers and Forecast to 2026 Cole Reports - Cole of Duty

Persistence Market Research recently published a market study that sheds light on the growth prospects of the global Healthcare Nanotechnology (Nanomedicine) market during the forecast period (20XX-20XX). In addition, the report also includes a detailed analysis of the impact of the novel COVID-19 pandemic on the future prospects of the Healthcare Nanotechnology (Nanomedicine) market. The report provides a thorough evaluation of the latest trends, market drivers, opportunities, and challenges within the global Healthcare Nanotechnology (Nanomedicine) market to assist our clients arrive at beneficial business decisions.

The recent published research report sheds light on critical aspects of the global Healthcare Nanotechnology (Nanomedicine) market such as vendor landscape, competitive strategies, market drivers and challenges along with the regional analysis. The report helps the readers to draw a suitable conclusion and clearly understand the current and future scenario and trends of global Healthcare Nanotechnology (Nanomedicine) market. The research study comes out as a compilation of useful guidelines for players to understand and define their strategies more efficiently in order to keep themselves ahead of their competitors. The report profiles leading companies of the global Healthcare Nanotechnology (Nanomedicine) market along with the emerging new ventures who are creating an impact on the global market with their latest innovations and technologies.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/6370

The recent published study includes information on key segmentation of the global Healthcare Nanotechnology (Nanomedicine) market on the basis of type/product, application and geography (country/region). Each of the segments included in the report is studies in relations to different factors such as market size, market share, value, growth rate and other quantitate information.

The competitive analysis included in the global Healthcare Nanotechnology (Nanomedicine) market study allows their readers to understand the difference between players and how they are operating amounts themselves on global scale. The research study gives a deep insight on the current and future trends of the market along with the opportunities for the new players who are in process of entering global Healthcare Nanotechnology (Nanomedicine) market. Market dynamic analysis such as market drivers, market restraints are explained thoroughly in the most detailed and easiest possible manner. The companies can also find several recommendations improve their business on the global scale.

The readers of the Healthcare Nanotechnology (Nanomedicine) Market report can also extract several key insights such as market size of varies products and application along with their market share and growth rate. The report also includes information for next five years as forested data and past five years as historical data and the market share of the several key information.

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/6370

Global Healthcare Nanotechnology (Nanomedicine) Market by Companies:

The company profile section of the report offers great insights such as market revenue and market share of global Healthcare Nanotechnology (Nanomedicine) market. Key companies listed in the report are:

Key players in the global nanomedicine market include: Abbott Laboratories, CombiMatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd., and UCB (Union chimique belge) S.A.

Key geographies evaluated in this report are:

Key features of this report

Global Healthcare Nanotechnology (Nanomedicine) Market by Geography:

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/6370

Some of the Major Highlights of TOC covers in Healthcare Nanotechnology (Nanomedicine) Market Report:

Chapter 1: Methodology & Scope of Healthcare Nanotechnology (Nanomedicine) Market

Chapter 2: Executive Summary of Healthcare Nanotechnology (Nanomedicine) Market

Chapter 3: Healthcare Nanotechnology (Nanomedicine) Industry Insights

Chapter 4: Healthcare Nanotechnology (Nanomedicine) Market, By Region

Chapter 5: Company Profile

And Continue

Link:
Healthcare Nanotechnology (Nanomedicine) Market to be Moderately Disrupted by Covid-19 Outbreak, Owing to Abc Issues - Cole of Duty

(MENAFN - iCrowdNewsWire) Apr 16, 2020

Nanotechnology in Cancer Treatment Market 2020

New Study Reports "Nanotechnology in Cancer Treatment Market 2020 Global Market Analysis, Opportunities, Challenges, Strategies and Forecasts 2025" has been Added on WiseGuyReports.

Report Summary:

The purpose of the report is to provide a comprehensive and detailed analysis for the industry Nanotechnology in Cancer Treatment . The report takes 2020 as the base year and considers a wide range of factors affecting the industry to provide a forecast still the year 2026. The information provided by the report can be used by industry and market analysts as well as by people who have an interest in the industry. The data used in the report is reliable and accurate. Primary and secondary research has been conducted to collect the data. The data in the report has been analysed using a wide range of mathematical and statistical metrics so as to provide the users of the report with quantifiable numbers that can be used to compare the performance of the industry with others of the same type. Methods like Price Trend Analysis. SWOT, Porters 5 Forces have been made use to prepare the report and give a reliable analysis of the industry.

This report presents a comprehensive overview, market shares, and growth opportunities of Nanotechnology in Cancer Treatment market by type, application, key manufacturers and key regions and countries.

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Abbott LaboratoriesCelgene CorporationCombimatrix CorporationSigma-Tau Pharmaceuticals Inc.Johnson & JohnsonGE HealthcareNanosphere Inc.Mallinckrodt PlcPfizer, Inc.Merck & Company Inc.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5185514-global-nanotechnology-in-cancer-treatment-market-growth-status

This study considers the Nanotechnology in Cancer Treatment value generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7. NanoparticlesNanorodsNanofibersGrapheneMetal-Organic FrameworksNanobiosensorsNanofluidic DevicesNanotools

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8. Cancer DetectionImagingDrug DeliveryRadiotherapyImmunotherapyPhototherapy

Enquiry Before Buying@ https://www.wiseguyreports.com/enquiry/5185514-global-nanotechnology-in-cancer-treatment-market-growth-status

If you have any special requirements, please let us know and we will offer you the report as you want.

Segmental Analysis: -

The industry Nanotechnology in Cancer Treatment is segmented on the basis of the applications, end-users as well as the type of products and services it provides. The report therefore studies the industry on the basis of these segments. The report provides detailed data related to the applications that drive the growth of the industry. The report also discusses the products and services and their end-users who make a significant contribution to the revenue of the industry Nanotechnology in Cancer Treatment. New product innovations by the industry are also talked about in the report.

Major Key Points from Table of Content:

1 Scope of the Report 1.1 Market Introduction1.2 Research Objectives1.3 Years Considered1.4 Market Research Methodology1.5 Economic Indicators1.6 Currency Considered

11 Key Players Analysis11.1 Abbott Laboratories 11.1.1 Company Details11.1.2 Nanotechnology in Cancer Treatment Product Offered11.1.3 Abbott Laboratories Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)11.1.4 Main Business Overview11.1.5 Abbott Laboratories News 11.2 Celgene Corporation 11.2.1 Company Details11.2.2 Nanotechnology in Cancer Treatment Product Offered11.2.3 Celgene Corporation Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)11.2.4 Main Business Overview11.2.5 Celgene Corporation News 11.3 Combimatrix Corporation 11.3.1 Company Details11.3.2 Nanotechnology in Cancer Treatment Product Offered11.3.3 Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)11.3.4 Main Business Overview11.3.5 Combimatrix Corporation News 11.4 Sigma-Tau Pharmaceuticals Inc. 11.4.1 Company Details11.4.2 Nanotechnology in Cancer Treatment Product Offered11.4.3 Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)11.4.4 Main Business Overview11.4.5 Sigma-Tau Pharmaceuticals Inc. News 11.5 Johnson & Johnson 11.5.1 Company Details11.5.2 Nanotechnology in Cancer Treatment Product Offered11.5.3 Johnson & Johnson Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)11.5.4 Main Business Overview11.5.5 Johnson & Johnson News 11.6 GE Healthcare 11.6.1 Company Details11.6.2 Nanotechnology in Cancer Treatment Product Offered11.6.3 GE Healthcare Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)11.6.4 Main Business Overview11.6.5 GE Healthcare News 11.7 Nanosphere Inc. 11.7.1 Company Details11.7.2 Nanotechnology in Cancer Treatment Product Offered11.7.3 Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)11.7.4 Main Business Overview11.7.5 Nanosphere Inc. News 11.8 Mallinckrodt Plc 11.8.1 Company Details11.8.2 Nanotechnology in Cancer Treatment Product Offered11.8.3 Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)11.8.4 Main Business Overview11.8.5 Mallinckrodt Plc News 11.9 Pfizer, Inc. 11.9.1 Company Details11.9.2 Nanotechnology in Cancer Treatment Product Offered11.9.3 Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)11.9.4 Main Business Overview11.9.5 Pfizer, Inc. News 11.10 Merck & Company Inc.

Continued..

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

MENAFN1604202000703403ID1100036429

View original post here:
Global Nanotechnology in Cancer Treatment Market 2020 Industry Analysis, Opportunities, Segmentation & Forecast To 2025 - MENAFN.COM

Its not an Avengers Movie Indeed, but the global threat lies on head of whole humanity and Nano tech, is indeed not a science fiction . But before going further deep . lets see what nano-tech is.

Nanotechnology is science, engineering, and technology conducted at the nano scale, which is about 1 to 100 nano meters.

Nano science and nanotechnology are the study and application of extremely small things and can be used across all the other science fields, such as chemistry, biology, physics, materials science, and engineering.

The rapidly increasing death tolls of COVID-19 have been a wake-up call for global health. Many researchers have recently turned their focus to this growing threat and a global effort is underway to halt its spread. Currently, there is no specific antiviral treatment available for COVID-19, but a wide range of pharmaceutical agents are being investigated. Meanwhile, among various fields of science and technology, nanotechnology has great potential to be of enormous help in the prevention, diagnosis, and treatment of COVID-19.

At the prevention stage, nano fiber-based facial respirators, along with nanotechnology-enabled highly effective antimicrobial and antiviral disinfectants, have been the first personal protective means that can prevent the spread of the virus; furthermore, extensive research is underway to develop a vaccine for COVID-19 based on different nano materials. In diagnostics, nanotechnology has shown considerable promise in designing sensors for developing quick-response COVID-19 tests. Last but not least, at the treatment phase, nano medicines have been at the center of many researchers attention, some of which are currently being studied in clinical trials. Hence, nano technologists are carrying out their social responsibility to tackle the ongoing global health emergency.

Currently the most widely used chemical disinfection protocols, halogenated disinfection or solvent/detergent strategies, suffer from a variety of limitations for suppression of environmental virus, such as the production of toxic by products as well as the low disinfect efficiency.Within this context, it is in urgent need to develop a novel strategy to guard against the environmental virus with high efficiency,low cost and minimized contamination.We are especially intrigued by the naturally occurring minerals that possess unique structure, facilitate large-scale production and affect the biological responses of viruses.

As known, nature derived graphene oxide (GO) nano materials is a promising chemical platform for various biomedical applications including protein adsorption,bacterial disinfection,bio reduction,and biosensors.It is worthy of note that GO based materials exhibits a physical toxicity associated with the interaction with cells or tissues. For instances, GO can destruct bacterial membranes by direct inorganic-bio molecule interactions;the attached proteins on GO always result in altering intrinsic structures and denature effects. Moreover, the interplay between GO and microbes have been demonstrated, attributing to the bio reduction of the oxygen-containing functionalities via bacterial respiration.Considering the versatile GO-bio-molecule interactions, we postulate that GO materials could potentially serve as a novel and promising candidate for virus prevention.

Graphene or GO particles can actually be used as the virus detectors or as the virus sensors since,The large surface area and good electrical conductivity of graphene allow it to act as an electron wire between the redox centers of an enzyme or protein and an electrodes surface, which make it a very excellent material for the design of electrochemical biosensors. Graphene promotes the different rapid electron transfers that facilitate accurate and selective detection of cytochrome-c, -nicotinamide adenine dinucleotide, haemoglobin, biomolecules such as glucose, cholesterol, ascorbic acid, uric acid, dopamine and hydrogen peroxide.

Graphene can be used to detect the protein shell found in the coronaviruses, which could be really faster and feasible approach in diagnoses of the patients and to reduce the spread .

The world is at war indeed and if we dont work together with all out potential then this pandemic could actually be the sign of The Great Filter.

Nanotechnology has recently come out from labs as experiments to products as an application and as the research continues the further we will know about its properties.

A very Big Thanks and Shout out to all the Medical Staffs and people who are putting their lives at risks to fight this WAR. You guys are the Real AVENGERS!Stay at home , Stay Safe Everyone

More here:
Nanotechnology, the Noble Prize winning tech, can it offer something for the Global War against - Elemental